Gal-3, therefore, represents a significant predictor of mortality risk in patients with heart failure, after adjustment for age and sex, and severity of HF and renal dysfunction, as assessed by NT-proBNP and estimated glomerular filtration rate, respectively [94]. The gene discussed is NPPB; the disease is heart failure.